Evidence map›Paper›PMID 29343749›Full record

ArticleScientific reports2018

Testosterone boosts physical activity in male mice via dopaminergic pathways.

Ferran Jardí, Michaël R Laurent, Nari Kim, Rougin Khalil, Dimitri De Bundel, Ann Van Eeckhaut, Lawrence Van Helleputte, Ludo Deboel, Vanessa Dubois, Dieter Schollaert and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A novel model to study the impact of gender-affirming therapy on bone in young male mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Ferran JardíClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Michaël R LaurentMolecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49 PO box 901, 3000, Leuven, Belgium.
Nari KimClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Rougin KhalilClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Dimitri De BundelDepartment of Pharmaceutical Chemistry and Drug Analysis, VUB, Laarbeeklaan 103, 1090, Brussels, Belgium.
Ann Van EeckhautDepartment of Pharmaceutical Chemistry and Drug Analysis, VUB, Laarbeeklaan 103, 1090, Brussels, Belgium.
Lawrence Van HelleputteLaboratory of Neurobiology, VIB Center for Brain and Disease Research and KU Leuven, Herestraat 49 PO box 602, 3000, Leuven, Belgium.
Ludo DeboelClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Vanessa DuboisMolecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49 PO box 901, 3000, Leuven, Belgium.
Dieter SchollaertClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Brigitte DecallonneClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.
Geert CarmelietClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium.ORCID http://orcid.org/0000-0001-8324-4462
Ludo Van den BoschLaboratory of Neurobiology, VIB Center for Brain and Disease Research and KU Leuven, Herestraat 49 PO box 602, 3000, Leuven, Belgium.
Rudi D'HoogeLaboratory of Biological Psychology, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102, 3000, Leuven, Belgium.
Frank ClaessensMolecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49 PO box 901, 3000, Leuven, Belgium.ORCID http://orcid.org/0000-0002-8676-7709
Dirk VanderschuerenClinical and Experimental Endocrinology, Department of Clinical and Experimental Medicine, KU Leuven, Herestraat 49 PO box 902, 3000, Leuven, Belgium. dirk.vanderschueren@uzleuven.be.
KU Leuven · BEVIB-KU Leuven Center for Brain & Disease Research · BEInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low testosterone (T) in men, especially its free fraction, has been associated with loss of energy. In accordance, orchidectomy (ORX) in rodents results in decreased physical activity. Still, the mechanisms through which T stimulates activity remain mostly obscure. Here, we studied voluntary wheel running behavior in three different mouse models of androgen deficiency: ORX, androgen receptor (AR) knock-out (ARKO) and sex hormone binding globulin (SHBG)-transgenic mice, a novel mouse model of "low free T". Our results clearly show a fast and dramatic action of T stimulating wheel running, which is not explained by its action on muscle, as evidenced by neuromuscular studies and in a muscle-specific conditional ARKO mouse model. The action of T occurs via its free fraction, as shown by the results in SHBG-transgenic mice, and it implies both androgenic and estrogenic pathways. Both gene expression and functional studies indicate that T modulates the in vivo sensitivity to dopamine (DA) agonists. Furthermore, the restoration of wheel running by T is inhibited by treatment with DA antagonists. These findings reveal that the free fraction of T, both via AR and indirectly through aromatization into estrogens, stimulates physical activity behavior in male mice by acting on central DA pathways.

Indexed as

AndrogensAnimalsDopamineDopaminergic NeuronsMaleMiceMice, Inbred C57BLMice, TransgenicMotor ActivityOrchiectomyPhysical Conditioning, AnimalReceptors, AndrogenRunningTestosteroneAndrogensDopamineReceptors, AndrogenTestosterone

Identifiers

PMID29343749
PMCPMC5772634
OpenAlexW2783725961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.